AnteoTech is pleased to provide a presentation with an overview of the Company's progress on #LifeSciences and #Energy department. View here: https://t.co/20g7ll1K7K $ADO #biotech
$ADO CEO Derek Thomson spoke with the @couriermail following the Company's #COVID19 antigen rapid test advancing in Europe and the recent CE Mark registration for EuGeni Reader and COVID-19 ART. To read: https://t.co/1CQIKnHBUS #lifesciences#pointofcare#health#tech#news
Queensland company @AnteoTech_'s rapid COVID-19 test has been given the tick by European authorities.
We backed AnteoTech with $1.4m to progress this vital product from prototype through to launch, as part of our strategy for economic recovery.
#qldjobs
AnteoTech (ADO) has opened strong on the ASX today after joining a nationwide, four-year collaborative battery research project.
https://t.co/kYGbyJNrov
#themarketherald#asxnews $ADO $ADO.AX
AnteoTech has executed a Project Participation Agreement with the Future Battery Industries CRC, for collaboration in “The Super Anode Project”. Read more: https://t.co/A2FkC8v4ek #anode#silicon#battery#energy#news#ASX $ADO
$SYA $PLL $ADO
#ASX#news 5/04/2021
NEUTRAL (0.5): Azure
These ASX shares have doubled in value in 2021
https://t.co/l1W5XLvUhF
Source: FoolComAu
Newsletter https://t.co/DNabYRzkB9 || My version of #fintech
Energy: AnteoTech’s technology contributes to #lithiumion#battery cells with aim of up to 75% higher #energy capacity vs. conventional #graphite cells
View presentation here: https://t.co/QWa8wjuNNc $ADO #ASX
Energy: How AnteoTech’s combined technology solutions could affect #battery#energy storage as a result of enhanced #silicon integration��️
View presentation here: https://t.co/QWa8wjuNNc $ADO #ASX
Energy: AnteoTech’s technology contributes to #lithiumion#battery cells with aim of up to 75% higher #energy capacity vs. conventional #graphite cells
View presentation here: https://t.co/QWa8wjuNNc $ADO #ASX
Reports suggest LFA market will rise significantly due to high rate of demand for #COVID19 LFIA test globally in short term. AnteoTech believe market acceleration will continue even with the vaccine introduction for at least 3 years. https://t.co/QWa8wjuNNc #lifescience $ADO #ASX